Several clinical characteristics differed among patients in the HCV-HCC versus HCV groups including age, sex, Child-Pugh grading, cirrhosis, individual biomarkers of AFP, PIVKA-II, and AFP-L3%, and diagnostic scores of ASAP and GALAD, with all P < 0.05. This evidence concerns the gene AFP and Cirrhosis.